🇺🇸 Mistletoe extract in United States
21 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 21
Most-reported reactions
- Fatigue — 3 reports (14.29%)
- Angina Pectoris — 2 reports (9.52%)
- Arthralgia — 2 reports (9.52%)
- Asthenia — 2 reports (9.52%)
- Constipation — 2 reports (9.52%)
- Diarrhoea — 2 reports (9.52%)
- Gastrointestinal Haemorrhage — 2 reports (9.52%)
- Headache — 2 reports (9.52%)
- Hypoaesthesia — 2 reports (9.52%)
- International Normalised Ratio Increased — 2 reports (9.52%)
Other Oncology approved in United States
Frequently asked questions
Is Mistletoe extract approved in United States?
Mistletoe extract does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Mistletoe extract in United States?
Rambam Health Care Campus is the originator. The local marketing authorisation holder may differ — check the official source linked above.